MedTrace Logo

Vanguard Rocc Post Market Surveillance

NCT03664791 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 450

Last updated 2024-04-10

No results posted yet for this study

Summary

The objective of this project is to obtain prospective, multi-center, long term (10 year) clinical data on the Vanguard Rocc knee prosthesis. Patient and knee function will be collected along with knee stability, the knee motion, functional recuperation, radiographic and survivorship data.

Conditions

  • Osteoarthritis, Knee
  • Rheumatoid Arthritis
  • Traumatic Arthritis
  • Posttraumatic Deformity
  • Varus Deformity
  • Valgus Deformity
  • Osteotomy
  • Arthrodesis

Interventions

PROCEDURE

Vanguard Rocc

Patient operated with the Vanguard Rocc knee prosthesis

Sponsors & Collaborators

  • Zimmer Biomet

    lead INDUSTRY

Principal Investigators

  • Paola Vivoda · Zimmer Biomet

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-10-23
Primary Completion
2024-12-31
Completion
2025-12-31

Countries

  • Belgium
  • Denmark
  • France
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03664791 on ClinicalTrials.gov